(Q34188508)

31 July 2017

1 reference

title

Current pharmacogenomic approaches to clinical drug development (English)

1 reference

31 July 2017

1 reference

Murphy MP

1

1 reference

31 July 2017

publication date

1 May 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

115-123

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Genetically determined drug-metabolizing activity and desipramine-associated cardiotoxicity: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.2.115

21 January 2018

Identifiers

DOI

10.1517/14622416.1.2.115

1 reference

31 July 2017

1 reference